Director, CMC Regulatory Affairs

About the role

Vir Biotechnology is seeking an a highly motivated, self-driven and enthusiastic Director of Regulatory CMC accountable for ensuring all assigned products have a successful regulatory CMC strategy for clinical development and commercialization. You should bring both a track record of successful regulatory submissions that demonstrates core capability in technical (CMC) development, as well as a passion to challenge conventional paradigms and influence global Health Authorities. We are looking for someone with experience or willingness to expand to cover multiple modalities. The ideal candidate will contribute to a culture of high performance, empowerment, continuous learning and diversity and inclusion. This position will work closely with the Technical Operations (CMC) functional groups and Regulatory Affairs department to plan and lead high quality regulatory submissions to health authorities. This role is located in our San Francisco headquarters with an expectation of 3 days per week in office.

Responsibilities

• As a member of the CMC project teams, provide strategic CMC regulatory leadership to develop and execute sound regulatory strategies that meet global regulatory requirements and enable Vir business objectives
• Provide CMC regulatory expertise to enable global development and registration for INDs, CTAs, BLAs and MAAs
• Identify and communicate regulatory risks and facilitate the development and execution of risk mitigation strategies in concert with Technical Operation functions
• Plan strategy for and lead HA interactions for CMC specific issues
• Manage CMC regulatory changes throughout the product life cycle, including support for relevant quality systems related to change control, discrepancy management, as well as Health Authority inspection support (as applicable)
• Ensure overall dossier compliance with regulatory requirements
• Ensure compliance with internal SOP's and policies
• Contribute to regulatory excellence by identifying opportunities and supporting continuous improvement
• WHO YOU ARE AND WHAT YOU BRING
• B.S., M.S., Ph.D. or other relevant advanced degree or certificate
• 10+ years experience in pharmaceutical product development including strong global Regulatory CMC leadership
• Regulatory CMC experience leading both development projects (IND/CTA) and initial registration (BLA/MAA)
• Experience with CMC regulatory considerations for late stage and/or commercial large molecules (biologics) is required experience with combination product or oligonucleotide experience is a plus
• Preference will be given to candidates with recent experience with initial BLA and/or NDA (CMC sections). Management of US post-market, biologic product CMC changes is a plus
• Experience with Health Authority interactions is desirable
• Thorough understanding of major FDA, EMA, ICH, EudraLex CMC guidelines
• Global clinical filing experience (US, EU, UK, CA,). Working knowledge of other global clinical territories procedures a plus
• Ability to effectively present to Senior Management
• #LI-AS1
• #LI-Onsite
• WHO WE ARE AND WHAT WE OFFER
• The expected salary range for this position is $195,500 to $272,500. Actual pay will be determined based on experience, qualifications, geographic location, and other job-related factors.
• Applicants must currently be authorized to work for any employer in the U.S. We are unable to sponsor or take over sponsorship of an employment Visa at this time.
• All employment decisions at Vir Biotechnology are based on legitimate, non-discriminatory business requirements, job duties and individual qualifications. Employment decisions are made w

Benefits

Additional Information

Vir Biotechnology, Inc. is a clinical-stage biopharmaceutical company focused on powering the immune system to transform lives by discovering and developing medicines for serious infectious diseases and cancer. Its clinical-stage portfolio includes programs for chronic hepatitis delta and multiple PRO-XTEN ® dual-masked T-cell engagers across validated targets in solid tumor indications. Vir Biotechnology also has a preclinical portfolio of programs across a range of infectious diseases and oncologic malignancies. Vir Biotechnology has exclusive rights to the universal PRO-XTEN ® masking platform for oncology and infectious disease. PRO-XTEN ® is a trademark of Amunix Pharmaceuticals, Inc., a Sanofi company. We believe the success of our colleagues drives the success of our mission. We are committed to creating a company where everyone feels supported and encouraged to give their best.

Your Match

How well this role fits your profile.

Company Intel

What employees say

Worked at virbiotechnologyinc? Share your experience